retatrutide clinical trial obesity ⭐️topline results from TRIUMPH-1, a Phase 3 evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Retatrutide Helped Adults With Obesity

For safe disposal of used needles and pens, follow the FDA's guidance on safe sharps disposal

Liraglutide acts faster but requires daily dosing, while tirzepatide targets an additional hormone pathway that may make it more potent for weight loss

Strength Training with Semaglutide Strength training with semaglutide helps counteract muscle loss while enhancing fat reduction

Mean age was 56, 81.6% were women, and 60.9% were white

Some GLP-1 medications activate a single gut hormone, while others activate multiple hormones for additional effects.We recommend discussing with your Seriously Health provider to determine which GLP-1 medication best fits your individual needs and goals

A good bariatric recommendation should be individualized